MedTrace Logo

Effects of Articaine Computer-controlled and Conventional Delivery for Anterior and Middle Superior Alveolar Nerve Block

NCT02440347 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2015-07-24

No results posted yet for this study

Summary

The purpose of this study was to investigate and compare pulpal anesthesia and cardiovascular parameters obtained with 0.6 ml of 4% articaine with epinephrine (1:100.000) for anterior and middle superior alveolar nerve (AMSA) block performed by standard and computer-controlled delivery in healthy volunteers.

Conditions

  • Local Anesthesia

Interventions

DEVICE

Computer controlled anesthetic delivery by Anaeject

Single dose of 0.6ml 4% articaine with epinephrine (1:100.000) delivered by computer controlled local anesthetic delivery system (Anaeject).

DEVICE

Conventional anesthetic delivery by carpule syringe

Single dose of 0.6ml 4% articaine with epinephrine (1:100.000) delivered by conventional syringe (carpule syringe).

Sponsors & Collaborators

  • University of Belgrade

    lead OTHER

Principal Investigators

  • Bozidar M Brkovic, DDS, PhD · School of Dental Medicine, University of Belgrade

  • Dejan Cetkovic, DDS · School of Dental Medicine, University of Belgrade

  • Vladimir M Biocanin, DDS, PhD · Faculty of Pharmacy and Health, University of Travnik, Bosnia and Herzegovina

  • Marija S Milic, DDS · School of Dental Medicine, University of Belgrade

  • Ivana Brajic, DDS · School of Dental Medicine, University of Belgrade

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
30 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-06-30
Primary Completion
2015-06-30
Completion
2015-06-30

Countries

  • Serbia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02440347 on ClinicalTrials.gov